Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

Abstract Aims This analysis qualitatively describes the impact of hyperkalaemia (HK) and renin‐angiotensin‐aldosterone system inhibitor (RAASi) use on clinical outcomes in patients with heart failure (HF). Methods and results Patients were included if they were ≥18 years old; had a serum potassium r...

Full description

Bibliographic Details
Main Authors: Joseph B. Muhlestein, Jennifer Kammerer, Tami L. Bair, Kirk U. Knowlton, Viet T. Le, Jeffrey L. Anderson, Donald L. Lappé, Heidi T. May
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:ESC Heart Failure
Subjects:
Hyperkalaemia
LVEF
MACE
RAAS inhibitors
Heart failure
Online Access:https://doi.org/10.1002/ehf2.13164

Internet

https://doi.org/10.1002/ehf2.13164

Similar Items